CVR number 38628887
Industry 86.2300 Dental practice activities

Tandlæge Michelle Zamani Søe ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  2.8% 3.0% 1.8% 4.6% 2.4%  
Credit score (0-100)  61 57 70 46 63  
Credit rating  BBB BBB A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.5 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  2,477 2,919 3,432 3,138 4,225  
EBITDA  543 512 748 218 954  
EBIT  287 257 430 -281 418  
Pre-tax profit (PTP)  82.4 42.5 195.6 -544.1 98.4  
Net earnings  64.3 37.7 147.8 -424.6 76.8  
Pre-tax profit without non-rec. items  82.4 42.5 196 -544 98.4  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  842 706 1,307 2,209 1,869  
Shareholders equity total  -178 -141 7.1 -417 -341  
Interest-bearing liabilities  2,094 1,511 1,949 3,550 3,195  
Balance sheet total (assets)  3,405 3,616 3,662 4,826 4,290  
Net Debt  1,967 937 1,855 3,469 3,144  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,477 2,919 3,432 3,138 4,225  
Gross profit growth  7.3% 17.8% 17.6% -8.5% 34.6%  
Employees  5 5 6 8 6  
Employee growth %  -16.7% 0.0% 20.0% 33.3% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,405 3,616 3,662 4,826 4,290  
Balance sheet change%  -1.3% 6.2% 1.3% 31.8% -11.1%  
Added value  542.9 512.3 747.6 36.2 953.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -511 -511 163 284 -996  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 -1.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.6% 8.8% 12.5% -9.0% 9.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  7.9% 7.0% 11.6% -6.3% 8.5%  
ROI %  11.5% 14.0% 24.8% -10.2% 12.4%  
ROE %  1.9% 1.1% 8.2% -17.6% 1.7%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -5.1% -3.9% 0.2% -8.5% -7.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  362.4% 182.8% 248.1% 1,592.9% 329.6%  
Gearing %  -1,173.7% -1,073.7% 27,326.4% -850.3% -937.8%  
Net interest  0 0 0 0 0  
Financing costs %  8.3% 11.9% 13.6% 9.6% 9.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.2 0.4 0.2 0.3 0.3  
Current Ratio  0.3 0.4 0.2 0.3 0.3  
Cash and cash equivalent  126.9 574.0 94.5 80.6 51.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,291.4 -1,325.5 -2,054.8 -1,826.2 -1,618.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  109 102 125 5 159  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  109 102 125 27 159  
EBIT / employee  57 51 72 -35 70  
Net earnings / employee  13 8 25 -53 13